ArticleChemSusChem2025
Organic Interlayer for Enhanced Buried Interfaces in Wide-Bandgap Perovskite Solar Cells.
Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tuning the performances of perovskite solar cells using effective organic molecular hole-transporting materials: a review.Frontiers in chemistry · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Achieving high performance and stability in wide-bandgap perovskite solar cells (PSCs) is essential for the development of tandem solar cells capable of surpassing the theoretical efficiency limit of single-junction photovoltaic (PV)devices. However, the performance of wide-bandgap PSCs remains challenging, primarily due to nonradiative recombination at the interfaces. An interlayer applied at the buried interface between the hole transport layer and the perovskite in a p-i-n architecture can play a pivotal role, as it is critical for efficient charge transport, extraction, and the formation of high-quality perovskite films. In this work, a donor-acceptor architectural quinoxaline-based organic interlayer specifically designed for the interface between NiO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.